Laxapana PLC (COSE:LITE.N0000)
0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Laxapana Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,871 | 3,358 | 999.52 | 915.64 | 868.41 | |
Revenue Growth (YoY) | 15.31% | 235.92% | 9.16% | 5.44% | 15.29% |
Cost of Revenue | 2,703 | 2,512 | 738.93 | 525.18 | 637.97 |
Gross Profit | 1,168 | 845.55 | 260.6 | 390.46 | 230.43 |
Selling, General & Admin | 644.48 | 632.5 | 345.18 | 232.84 | 137.62 |
Other Operating Expenses | -64.5 | -89.42 | -128.05 | -95.98 | -73.19 |
Operating Expenses | 579.98 | 543.08 | 217.13 | 136.86 | 64.44 |
Operating Income | 588.33 | 302.47 | 43.47 | 253.59 | 166 |
Interest Expense | -69.33 | -72.62 | -37.4 | -22.05 | -24.82 |
Interest & Investment Income | - | 7.53 | 6.99 | 1.93 | 24.57 |
Currency Exchange Gain (Loss) | - | 15.51 | 4.42 | -28.93 | -34.73 |
Other Non Operating Income (Expenses) | -0 | - | - | - | - |
EBT Excluding Unusual Items | 519 | 252.89 | 17.47 | 204.54 | 131.01 |
Asset Writedown | - | 1.26 | 33.25 | 8.76 | - |
Other Unusual Items | - | - | 248.71 | - | - |
Pretax Income | 519 | 254.15 | 299.43 | 213.3 | 131.01 |
Income Tax Expense | 197.68 | 86.89 | 43.88 | 79.31 | 30.89 |
Net Income | 321.32 | 167.26 | 255.54 | 134 | 100.12 |
Net Income to Common | 321.32 | 167.26 | 255.54 | 134 | 100.12 |
Net Income Growth | 92.11% | -34.55% | 90.71% | 33.84% | 18.19% |
Shares Outstanding (Basic) | 66 | 66 | 66 | 66 | 66 |
Shares Outstanding (Diluted) | 66 | 66 | 66 | 66 | 66 |
Shares Change (YoY) | 0.04% | - | - | - | 57.14% |
EPS (Basic) | 4.85 | 2.53 | 3.86 | 2.02 | 1.51 |
EPS (Diluted) | 4.85 | 2.53 | 3.86 | 2.02 | 1.51 |
EPS Growth | 92.03% | -34.55% | 90.71% | 33.84% | -24.79% |
Free Cash Flow | 301.74 | 17.83 | -63.98 | 63.09 | -90.58 |
Free Cash Flow Per Share | 4.55 | 0.27 | -0.97 | 0.95 | -1.37 |
Dividend Per Share | - | 1.500 | 1.500 | 2.000 | 0.750 |
Dividend Growth | - | - | -25.00% | 166.67% | -25.00% |
Gross Margin | 30.18% | 25.18% | 26.07% | 42.64% | 26.53% |
Operating Margin | 15.20% | 9.01% | 4.35% | 27.70% | 19.11% |
Profit Margin | 8.30% | 4.98% | 25.57% | 14.63% | 11.53% |
Free Cash Flow Margin | 7.79% | 0.53% | -6.40% | 6.89% | -10.43% |
EBITDA | 651.72 | 358.49 | 69.87 | 262.25 | 169.18 |
EBITDA Margin | 16.83% | 10.68% | 6.99% | 28.64% | 19.48% |
D&A For EBITDA | 63.4 | 56.02 | 26.4 | 8.66 | 3.19 |
EBIT | 588.33 | 302.47 | 43.47 | 253.59 | 166 |
EBIT Margin | 15.20% | 9.01% | 4.35% | 27.70% | 19.11% |
Effective Tax Rate | 38.09% | 34.19% | 14.66% | 37.18% | 23.58% |